OPKO Health, Inc. OPK today announced that the Company repurchased approximately 2.4 million shares of its common stock for approximately $7.8 million, including commissions, from an early investor in
Acuity Pharmaceuticals, the Company's predecessor. The repurchase was funded with cash on hand.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in